Search

Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center.

… Saturday, October 1, 2011 Summary Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center as a member of the Cancer Biology and Genetics Program in the Sloan Kettering Institute and Chair of the Geoffrey Beene Cancer Research Center. Scott W. Lowe has joined Memorial Sloan Kettering Cancer Center

A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells.

… Thursday, December 1, 2011 Summary A new therapy tested in mouse models appears to harness neutrophils, a type of white blood cell, to effectively prevent the spread of breast cancer cells. A multidisciplinary team from Memorial Sloan Kettering Cancer Center has published research suggesting a potential

The program, established through a $25 million grant from the Stavros Niarchos Foundation (SNF) as part of its Global Health Initiative, aims to improve outcomes for pediatric cancer patients through international healthcare collaborations.

… Tuesday, June 18, 2024 The program, established through a $25 million grant from the Stavros Niarchos Foundation (SNF) as part of its Global Health Initiative, aims to improve outcomes for pediatric cancer patients through international healthcare collaborations. Memorial Sloan Kettering Cancer Center

In their 60-year love story, Bobbie and Barbara went through multiple cancers together. Now MSK social worker Sabrina Feldman is helping Bobbie to find new meaning, connection, and comfort, as he continues treatment without Barbara by his side.

… Wednesday, August 28, 2024 Their love story began 60 years ago, when Bobbie Walker married Barbara Ann Hursh just three months after they met. “We became co-partners in this life we chose together,” says Bobbie, an artist and former art director at some of the most prestigious advertising firms in New

Attendees met and shared ideas on cancer genetics and metastasis, stem cell biology, and more.

… Wednesday, April 20, 2016 Memorial Sloan Kettering, Weill Cornell Medical College, and Rockefeller University hosted the Second Annual New York Graduate Student Symposium on Cancer and Cell Biology on Thursday, March 24. Students from the NYU School of Medicine, Cold Spring Harbor Laboratory, Columbia

A collaborative team of leaders in the field of cancer immunology has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.

… Wednesday, November 19, 2014 A collaborative team of leaders in the field of cancer immunology from Memorial Sloan Kettering Cancer Center has made a key discovery that advances the understanding of why some patients respond to ipilimumab, an immunotherapy drug, while others do not.  MSK was at the forefront

Memorial Sloan Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic.

… Tuesday, November 26, 2013 Summary Memorial Sloan Kettering endocrinologist Azeez Farooki discusses the risk factors associated with diabetes and why cancer treatment may be more complicated for those who are diabetic. More than 25 million people in the United States have been diagnosed with diabetes

New MSK research highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately summarize cancer patients’ experiences with pain; and finds proton therapy is effective at treating leptomeningeal metastasis.

… Thursday, September 25, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) highlights the importance of tumor location in metastasis; shows how regulatory T cells work with sensory nerves in the skin to restrain pain and inflammation; explores whether a large language model can adequately

To explore new treatment options – and potentially change the standard of care for resected lung cancer – Memorial Sloan Kettering Cancer Center is enrolling patients in a National Cancer Institute-sponsored trial.

… Friday, September 23, 2016 Memorial Sloan Kettering Cancer Center is proud to be participating in the Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). ALCHEMIST is a large, multicenter trial sponsored by the National Cancer Institute to assess newly available and

Sloan Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director (ACD) at the National Institutes of Health.

… Thursday, May 1, 2008 Summary Sloan Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director (ACD) at the National Institutes of Health. Sloan Kettering Institute Director Thomas J. Kelly has been named a member of the Advisory Committee to the Director